Skip to main content

Grants

23,418 grants found

Compare

Assessing the longitudinal impact of Mediterranean diet interventions to reduce cognitive decline on gut microbiota composition and bile acid variety

open

NIA - National Institute on Aging

PROJECT SUMMARY/ABSTRACT Alzheimer’s disease is a progressive neurodegenerative disorder with a complex etiology affecting over six million individuals in the United States alone, with numbers projected to rise significantly as the population ages. Concomitant changes in gut microbiome and metabolome composition have been observed over the course of Alzheimer’s-related cognitive decline, suggesting host microbiota may mediate the pathophysiological processes of Alzheimer’s disease and related dementias. Gut microbes contribute to host metabolism through the production and modification of metabolites, such as bile acids, which collectively influence overall metabolic health. Lifestyle interventions, such as diet modification, are promising strategies for lowering dementia risk, and these modifications are also influential in regulating the gut microbiome. However, the long-term effects of specific dietary interventions on microbially-mediated bile acid profiles and their impact on cognitive decline remain poorly understood, motivating further investigation. This proposal seeks to apply advanced computational and algorithmic approaches to identify compositional and functional changes in the gut microbiome and metabolome over the course of longitudinal dietary interventions. Aim 1 of this proposal will unify three independent cohorts assessing the impact of adherence to the Mediterranean diet, a diet high in plants and healthy fats, on cognitive decline. By conducting phylogenetically-aware metagenomic analyses and network-based untargeted metabolomic analyses, this proposal aims to identify changes in microbial communities and bile acid profiles during Mediterranean dietary interventions, and correlate these changes with host phenotypes indicative of Alzheimer’s risk. Complementarily, Aim 2 of this proposal will assess the prognostic potential of gut microbiome and metabolome features by constructing and evaluating machine learning models to predict cognitive outcomes over the course of intervention. These efforts will deepen our understanding of the relationship between diet, the gut microbiome, bile acid proliferation, and cognitive health by employing standardized and reproducible methodological analyses across large cohorts. Ultimately, this research is poised to reveal mechanistic targets for future study, facilitating the development of novel diagnostic and therapeutic strategies for Alzheimer's disease in at-risk populations.

Up to $43K
2030-02-01
health research
Compare

Assessing the role of lncRNA SLAMR in the pathogenesis of Alzheimers disease

open

NIA - National Institute on Aging

SUMMARY The functions of long-noncoding RNAs (lncRNAs) as crucial regulators of transcription, epigenetic modifications, mRNA stability, localization, and translation indicate their potential involvement in Alzheimer's disease (AD) pathogenesis. Given the impairment of these fundamental cellular processes in AD, lncRNAs emerge as plausible targets. Consistent with this possibility, several studies have demonstrated altered expression of specific lncRNAs in various AD models. However, the precise roles, mechanisms, and cell-specific contributions of these lncRNAs in AD development remain unclear. This exploratory/developmental R21 proposal aims to systematically investigate the regulation of expression and function of lncRNA SLAMR in the pathogenesis of AD. SLAMR lncRNA was discovered from an unbiased screen of learning regulated lncRNAs. We find that SLAMR lncRNA in mouse CA1 is critical for synapse density, morphology, plasticity and memory. Importantly, we find that SLAMR functions as a key modulator of translation and structural plasticity. Gain of function of SLAMR resulted in enhanced translation and functional synapses. Our preliminary data show that SLAMR expression is impaired in APP knock-in (App NL-G-F) mouse model of AD. We will now assess the role of SLAMR mediated translation in App NL-G-F model and Tau model (PS19) of AD. Our systematic functional experiments are anticipated to unveil the role of SLAMR in the progression of AD pathogenesis. Successful completion of this proposal will shed light on the significance of lncRNAs in AD pathogenesis and influence the development of lncRNA-based therapeutics for AD.

Up to $507K
2028-01-31
health research